Novel noninvasive indices for the assessment of liver fibrosis in primary biliary cholangitis

Li,Yan; Zhang,Meng-Jun; Wang,Xue-Hong; Li,Su-Hua

doi:10.3892/br.2023.1689

Novel noninvasive indices for the assessment of liver fibrosis in primary biliary cholangitis

Authors:
- Yan Li
- Meng-Jun Zhang
- Xue-Hong Wang
- Su-Hua Li
View Affiliations

Affiliations: Department of Gastroenterology, The Affiliated Hospital of Qinghai University, Xining, Qinghai 810001, P.R. China
Published online on: November 13, 2023 https://doi.org/10.3892/br.2023.1689
Article Number: 1
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to investigate the accuracy of new noninvasive markers in predicting liver fibrosis among individuals with primary biliary cholangitis (PBC). This retrospective analysis included subjects with PBC who had liver biopsies. Scheuer's classification was used to determine the fibrosis stage. The bilirubin to albumin (Alb) ratio (BAR), fibrosis index based on the four factors (FIB‑4), γ‑glutamyl transpeptidase to platelet (PLT) ratio (GPR), red cell distribution width to PLT ratio (RPR), aspartate aminotransferase (AST) to alanine aminotransferase ratio (AAR), AST to PLT ratio index (APRI) and total bilirubin to PLT ratio (TPR) were calculated based on the laboratory parameters. A novel index called BARP was conceived as BAR x RPR. A total of 78 individuals with PBC were included in the study, 84.6% of whom had significant fibrosis, 30.8% had advanced fibrosis and 15.4% had cirrhosis. In the multivariate analysis, Alb was determined to be an independent predictor of advanced fibrosis (odds ratio=0.823, P=0.034). The area under the receiver operating characteristic curves (AUROCs) of the BAR, GPR, TPR and BARP were statistically significant in predicting severe fibrosis (P<0.05) and were 0.747, 0.684, 0.693 and 0.696, respectively. In assessing advanced fibrosis, the AUROCs for the AAR, APRI, BAR, FIB‑4, RPR, TPR and BARP were 0.726, 0.650, 0.742, 0.716, 0.670, 0.735 and 0.750, respectively. The AUROCs for the APRI, BAR, FIB‑4, RPR, TPR and BARP for cirrhosis prediction were 0.776, 0.753, 0.821, 0.819, 0.808 and 0.832, respectively. By comparing the AUROCs, it was demonstrated that the diagnostic capabilities of the BARP (P=0.021) and TPR (P=0.044) were superior to those of the APRI in predicting advanced fibrosis. In conclusion, the BAR, BARP and TPR were of predictive value for the grade of liver fibrosis in PBC and Alb had a diagnostic value in identifying early fibrosis. The aforementioned noninvasive indices may be used for predicting histologic stages of PBC.

View Figures

View References

1	You H, Duan W, Li S, Lv T, Chen S, Lu L, Ma X, Han Y, Nan Y, Xu X, et al: Guidelines on the diagnosis and management of primary biliary cholangitis (2021). J Clin Transl Hepatol. 11:736–746. 2023.PubMed/NCBI View Article : Google Scholar
2	Xu XY, Ding HG, Li WG, Xu JH, Han Y, Jia JD, Wei L, Duan ZP, Ling-Hu EQ and Zhuang H: Chinese guidelines on the management of liver cirrhosis (abbreviated version). World J Gastroenterol. 26:7088–7103. 2020.PubMed/NCBI View Article : Google Scholar
3	Cui XW, Li KN, Yi AJ, Wang B, Wei Q, Wu GG and Dietrich CF: Ultrasound elastography. Endosc ultrasound. 11:252–274. 2022.PubMed/NCBI View Article : Google Scholar
4	Chang Y, Guo C, Guo G, Yuan Z, Zhou X, Wang J, Han Z, Chen Y, Jia G and Han Y: Erythrocyte count is associated with prognosis in Chinese patients with primary biliary cholangitis. Exp Ther Med. 19:2075–2082. 2020.PubMed/NCBI View Article : Google Scholar
5	Tarantino G, Barrea L, Capone D, Citro V, Mosca T and Savastano S: Hematocrit values predict carotid intimal-media thickness in obese patients with non-alcoholic fatty liver disease: A cross-sectional study. Front Endocrinol (Lausanne). 9(203)2018.PubMed/NCBI View Article : Google Scholar
6	Sorokin A, Brown JL and Thompson PD: Primary biliary cirrhosis, hyperlipidemia, and atherosclerotic risk: A systematic review. Atherosclerosis. 194:293–299. 2007.PubMed/NCBI View Article : Google Scholar
7	Schulz M, Wilde ACB, Demir M, Müller T, Tacke F and Wree A: Shear wave elastography and shear wave dispersion imaging in primary biliary cholangitis-a pilot study. Quant Imaging Med Surg. 12:1235–1242. 2022.PubMed/NCBI View Article : Google Scholar
8	Cristoferi L, Calvaruso V, Overi D, Viganò M, Rigamonti C, Degasperi E, Cardinale V, Labanca S, Zucchini N, Fichera A, et al: Accuracy of transient elastography in assessing fibrosis at diagnosis in naïve patients with primary biliary cholangitis: A dual cut-off approach. Hepatology. 74:1496–1508. 2021.PubMed/NCBI View Article : Google Scholar
9	Meng Y, Liang Y and Liu M: The value of MRI in the diagnosis of primary biliary cirrhosis and assessment of liver fibrosis. PLoS One. 10(e0120110)2015.PubMed/NCBI View Article : Google Scholar
10	Wai CT, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS and Lok ASF: A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 38:518–526. 2003.PubMed/NCBI View Article : Google Scholar
11	Reinson T, Buchanan RM and Byrne CD: Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future. Clin Mol Hepatol. 29 (Suppl):S157–S170. 2023.PubMed/NCBI View Article : Google Scholar
12	Wang Z, Zhou Y, Yu P, Liu Y, Mei M, Bian Z, Shao W, Lv J, Li X, Lu W and Xu L: Retrospective evaluation of non-invasive assessment based on routine laboratory markers for assessing advanced liver fibrosis in chronic hepatitis B patients. Int J Gen Med. 15:5159–5171. 2022.PubMed/NCBI View Article : Google Scholar
13	Nakano T, Inoue K, Hirohara J, Arita S, Higuchi K, Omata M and Toda G: Long-term prognosis of primary biliary cirrhosis (PBC) in Japan and analysis of the factors of stage progression in asymptomatic PBC (a-PBC). Hepatol Res. 22:250–260. 2002.PubMed/NCBI View Article : Google Scholar
14	Vardar G, Okan MA, Karadag N, Topcuoglu S, Ozalkaya E, Karatepe HO and Karatekin G: Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time. Niger J Clin Pract. 25:1262–1268. 2022.PubMed/NCBI View Article : Google Scholar
15	Li Y, Liu H, Chen K, Wu X, Wu J, Yang Z, Yao L, Wen G, Zhang C, Chen X, et al: Pathological significance and prognostic roles of indirect bilirubin/albumin ratio in hepatic encephalopathy. Front Med (Lausanne). 8(706407)2021.PubMed/NCBI View Article : Google Scholar
16	Wang L, Sun K, Tian A, Liu Y, Zhang M, Zhou X and Han Y: Fenofibrate improves GLOBE and UK-PBC scores and histological features in primary biliary cholangitis. Minerva Med. 113:974–982. 2022.PubMed/NCBI View Article : Google Scholar
17	Warnes TW, Roberts SA, Smith A, Cope VM, Vales P, Haboubi NY and McMahon RF: Portal hypertension in primary biliary cholangitis: Prevalence, natural history and histological correlates. Eur J Gastroenterol Hepatol. 33:1595–1602. 2021.PubMed/NCBI View Article : Google Scholar
18	Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hübscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, et al: The British society of gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 67:1568–1594. 2018.PubMed/NCBI View Article : Google Scholar
19	Gherlan GS: Liver ultrasound elastography: More than staging the disease. World J Hepatol. 7:1595–1600. 2015.PubMed/NCBI View Article : Google Scholar
20	Yu JH, Lee HA and Kim SU: Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: Current and future. Clin Mol Hepatol. 29 (Suppl 1):S136–S149. 2023.PubMed/NCBI View Article : Google Scholar
21	Branchi F, Conti CB, Baccarin A, Lampertico P, Conte D and Fraquelli M: Non-invasive assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol. 20:14568–14580. 2014.PubMed/NCBI View Article : Google Scholar
22	Florea M, Serban T, Tirpe GR, Tirpe A and Lupsor-Platon M: Noninvasive assessment of hepatitis C virus infected patients using vibration-controlled transient elastography. J Clin Med. 10(2575)2021.PubMed/NCBI View Article : Google Scholar
23	Castera L, Friedrich-Rust M and Loomba R: Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 156:1264–1281.e4. 2019.PubMed/NCBI View Article : Google Scholar
24	Michalak A, Guz M, Kozicka J, Cybulski M, Jeleniewicz W, Lach T and Cichoż-Lach H: Red blood cell distribution width derivatives in alcohol-related liver cirrhosis and metabolic-associated fatty liver disease. World J Gastroenterol. 28:5636–5647. 2022.PubMed/NCBI View Article : Google Scholar
25	Jiang M, Yan X, Song X, Yan Q, Zhao Y, Wang L and Gao P: Total bile acid to platelet ratio: A noninvasive index for predicting liver fibrosis in primary biliary cholangitis. Medicine (Baltimore). 99(e20502)2020.PubMed/NCBI View Article : Google Scholar
26	Jiang X, Wang Y, Su Z, Yang F, Lv H, Lin L and Sun C: Red blood cell distribution width to platelet ratio levels in assessment of histologic severity in patients with primary biliary cholangitis. Scand J Clin Lab Invest. 78:258–263. 2018.PubMed/NCBI View Article : Google Scholar
27	Wang H, Xu H, Wang X, Wu R, Gao X, Jin Q and Niu J: Red blood cell distribution width to platelet ratio is related to histologic severity of primary biliary cirrhosis. Medicine (Baltimore). 95(e3114)2016.PubMed/NCBI View Article : Google Scholar
28	Meng J, Xu H, Liu X, Wu R and Niu J: Increased red cell width distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis. Medicine (Baltimore). 97(e13431)2018.PubMed/NCBI View Article : Google Scholar
29	Avcioğlu U, Eruzun H and Ustaoğlu M: The gamma-glutamyl transferase to platelet ratio for noninvasive evaluation of liver fibrosis in patients with primary biliary cholangitis. Medicine (Baltimore). 101(e30626)2022.PubMed/NCBI View Article : Google Scholar
30	Tahtaci M, Yurekli OT, Bolat AD, Balci S, Akin FE, Buyukasik NS and Ersoy O: Increased mean platelet volume is related to histologic severity of primary biliary cirrhosis. Eur J Gastroenterol Hepatol. 27:1382–1385. 2015.PubMed/NCBI View Article : Google Scholar
31	Hayashi M, Abe K, Fujita M, Takahashi A, Hashimoto Y and Ohira H: Serum Gas6 and Axl as non-invasive biomarkers of advanced histological stage in primary biliary cholangitis. Hepatol Res. 50:1337–1346. 2020.PubMed/NCBI View Article : Google Scholar